Boston Scientific CorpBSX

NYSEHealthcareSurgical & Medical Instruments & Apparatus
Price (close)
$43.92
Market cap
$64.8B
P/E
17.6x
Revenue (TTM)
$21.0B
Net income
$3.7B
Dividend yield
—
1-year total return
-55.2%
Net margin
17.5%
Revenue growth
13.5%
Debt / equity
0.51x

What Boston Scientific Corp does.

Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a broad range of interventional medical specialties. Our mission is to transform lives through innovative medical solutions that improve the health of patients around the world. As a medical technology leader for more than 45 years, we have advanced the practice of less-invasive medicine by helping physicians and other medical professionals diagnose and treat a wide range of diseases and medical conditions and improve patients’ quality of life by providing alternatives to surgery and other medical procedures that are typically traumatic to the body. We advance science for life by providing a broad range of high-performance solutions to address unmet patient needs and reduce the cost of health care. When used in this report, the terms "we," "us," "our" and "the Company" mean Boston Scientific Corporation and its divisions and subsidiaries.

We operate pursuant to five strategic imperatives. We aim to: Strengthen Category Leadership, Expand into High Growth Adjacencies, Drive Global Expansion, Fund the Journey to Fuel Growth and Develop Key Capabilities. We believe that our

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Revenue$9.9B$11.9B$12.7B$14.2B$16.7B$20.1B
Net income-$82.0M$1.0B$698.0M$1.6B$1.9B$2.9B
Free cash flow$1.1B$1.3B$938.0M$1.8B$2.6B$3.7B

More on BSX.

Figures from Boston Scientific Corp's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.